Coastwise Capital Group’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$556K Buy
7,105
+1,205
+20% +$97.2K 0.32% 69
2026
Q1
$511K Buy
5,900
+400
+7% +$38.3K 0.28% 72
2025
Q4
$528K Sell
5,500
-400
-7% -$38.9K 0.26% 81
2025
Q3
$562K Sell
5,900
-100
-2% -$9.19K 0.4% 60
2025
Q2
$523K Hold
6,000
0.42% 57
2025
Q1
$539K Sell
6,000
-300
-5% -$26.8K 0.45% 59
2024
Q4
$503K Sell
6,300
-200
-3% -$17.3K 0.4% 62
2024
Q3
$585K Buy
6,500
+1,100
+20% +$92.5K 0.48% 59
2024
Q2
$425K Hold
5,400
0.4% 65
2024
Q1
$471K Buy
5,400
+10
+0.2% +$853 0.44% 66
2023
Q4
$444K Buy
5,390
+690
+15% +$52.6K 0.45% 62
2023
Q3
$368K Buy
4,700
+2,200
+88% +$184K 0.42% 68
2023
Q2
$220K Hold
2,500
0.25% 103
2023
Q1
$202K Buy
+2,500
New +$204K 0.23% 109

Other funds holding MDT

Coastwise Capital Group's MDT Position: Q2 2026 in Review

Coastwise Capital Group increased its Medtronic (MDT) stake by 20% in Q2 2026, buying an estimated $97.2K and bringing the position to 7,105 shares worth $556K. The position accounts for 0.32% of the portfolio, ranked #69.

Coastwise Capital Group first reported a position in MDT in Q1 2023 and has held it in 14 quarters since. The position peaked at $585K in Q3 2024. 486 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Coastwise Capital Group held 7,105 shares of Medtronic worth $556K as of Q2 2026.
  • Coastwise Capital Group bought 1,205 Medtronic shares in Q2 2026, an estimated $97.2K.
  • Medtronic made up 0.32% of Coastwise Capital Group's portfolio in Q2 2026, its #69 holding.
  • Coastwise Capital Group first reported a position in Medtronic in Q1 2023 and has held it in 14 quarters since.
  • Coastwise Capital Group's Medtronic position peaked at $585K in Q3 2024.
  • 486 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Coastwise Capital Group's 13F filing for Q2 2026, filed 16 Jul 2026.